A kidney from a deceased donor can typically be preserved for 24 to 36 hours using standard cold storage, though kidneys have been successfully transplanted after 40 hours or more in certain circumstances. The preservation window depends on the donor type, the storage method used, and the kidney’s overall health. Every additional hour outside the body raises the risk of complications, so transplant teams work to minimize that time.
Standard Preservation Time Limits
Most transplant centers aim to keep cold storage time, known as cold ischemia time (CIT), under 24 hours for deceased donor kidneys. In practice, many transplants fall within the 16 to 24 hour range due to the logistics of matching, transporting, and preparing for surgery. Research grouping transplants into time brackets of 16 hours or less, 16 to 24, 24 to 32, 32 to 40, and over 40 hours shows that outcomes get progressively worse as time increases, but kidneys transplanted well beyond 24 hours still function successfully in many cases.
For living donor kidneys, the traditional target is much shorter: under 8 hours. Because living donor surgeries are scheduled in advance, the kidney often moves directly from one operating room to another, keeping preservation time minimal. That said, kidney paired donation programs, where donors and recipients are matched across different hospitals, have pushed living donor preservation times much higher. A study of shipped living donor kidneys found that 6% had cold ischemia times of 16 hours or more, with the longest recorded at 47 hours.
How Each Extra Hour Affects Outcomes
A large meta-analysis of nearly 60,000 kidney transplant recipients found that every additional hour of cold ischemia time increases the odds of delayed graft function (the kidney not working right away after surgery, requiring temporary dialysis) by about 5%. That may sound small per hour, but it compounds. A kidney preserved for 30 hours faces meaningfully higher risk than one preserved for 15.
The source of the donor kidney matters too. Kidneys from donors who died after circulatory death (DCD) are more vulnerable to preservation time than kidneys from brain-dead donors (DBD). A national registry analysis found that when CIT exceeded 24 hours, the 5-year survival rate with a functioning graft was 58.8% for DCD kidneys compared with 72.4% for DBD kidneys. For DCD kidneys, the risk of graft failure became significantly elevated compared to DBD kidneys at around 22 to 23 hours. Older donor kidneys are even more sensitive: DCD kidneys from 60-year-old donors showed significantly higher failure risk at just 19 hours of cold ischemia.
Importantly, longer preservation times were not associated with higher recipient death rates regardless of donor type. The main consequence is whether the kidney works immediately and how long it lasts, not whether the surgery itself becomes more dangerous. A recent UNOS analysis of over 4,000 DCD kidney pairs confirmed that cold ischemia times over 24 hours did not worsen long-term graft survival or patient survival, even though they did increase the likelihood of needing dialysis in the first week. The study’s authors argued that centers should accept these kidneys rather than discard them over preservation time concerns alone.
How Kidneys Are Preserved
The simplest and most common method is static cold storage: the kidney is flushed with a special preservation solution and placed on ice in a cooler, keeping it near 0 to 4°C. Cooling slows the organ’s metabolism dramatically, reducing its need for oxygen and nutrients while it sits outside the body. This approach is inexpensive and portable, which is why it remains the default for many transplant programs.
The more advanced alternative is hypothermic machine perfusion, where a device continuously pumps cold preservation fluid through the kidney’s blood vessels during transport. A Cochrane-level review of 14 studies found high-certainty evidence that machine perfusion reduces the risk of delayed graft function by 23% compared to simple cold storage. For DCD kidneys, which are already at higher risk, roughly one case of delayed graft function is prevented for every 7 kidneys placed on the machine. For DBD kidneys, the number needed to treat is about 14. Two studies also reported improved long-term graft survival with machine perfusion.
Normothermic Perfusion: A Newer Approach
Instead of keeping kidneys cold, normothermic machine perfusion maintains them at body temperature (37°C) with oxygenated blood or a blood-based solution, essentially keeping the organ “alive” and functioning outside the body. This allows transplant teams to assess the kidney’s quality before surgery by measuring urine output and other markers.
Clinical use is still limited but growing. The first clinical kidney transplant using this technique happened in 2011, with just 35 minutes of warm perfusion. Since then, trials have extended perfusion times considerably. A phase 1 trial tested up to 24 hours of oxygenated normothermic perfusion after standard cold storage. Animal studies have shown that 16 hours of continuous warm perfusion outperformed both cold storage and cold machine perfusion in early kidney function after transplant, and separate experiments demonstrated that stable 24-hour perfusion of human kidneys is feasible by recirculating the urine the kidney produces back into the fluid circuit.
This technology holds the potential to extend viable preservation times well beyond what cold storage allows, and to salvage kidneys that would otherwise be discarded. It is not yet standard practice at most centers, but several clinical trials are underway.
Why Some Kidneys Are Preserved Longer
Preservation time is rarely a deliberate choice. It reflects the real-world logistics of organ transplantation: how far the kidney needs to travel, how long it takes to find and prepare the recipient, and whether additional testing is needed. Kidneys shipped beyond 250 nautical miles from the donor hospital routinely face longer cold times, and national guidance now emphasizes that extended preservation should not be the primary reason to turn down an organ.
Some kidneys also take longer to place because they come from older donors or donors with medical complexities that make recipient centers hesitant. Paradoxically, these are the kidneys least tolerant of long preservation. A kidney from a 60-year-old DCD donor shows damage from cold ischemia earlier than one from a younger, healthier donor, yet it may sit longer while multiple programs evaluate and decline it. Machine perfusion can help offset some of this damage, which is one reason its use is expanding for higher-risk organs.
What This Means in Practice
If you’re on a transplant waiting list and receive a call about an available kidney, the organ has likely been outside the donor’s body for anywhere from a few hours to over 24 hours. Transplant teams factor cold ischemia time into their decision-making, but it is one variable among many, including donor age, kidney quality scores, and how well the organ matches your immune profile. A kidney with 28 hours of cold time from a young, healthy donor may offer better long-term outcomes than a kidney with 12 hours of cold time from an older donor with other risk factors.
The practical ceiling for successful transplantation with standard cold storage sits somewhere around 36 to 40 hours for most deceased donor kidneys, though outcomes beyond 24 hours are measurably worse on average. Machine perfusion pushes that window further and reduces complications within it. Normothermic perfusion may eventually redefine the limits entirely, but for now, the goal remains the same: get the kidney transplanted as quickly as possible while ensuring the best possible match.